DLO6002

Thuốc Gốc

Small Molecule

DLO6002 is developed by Summit Corporation and is in phase I of clinical trials for the treatment of Parkinson's disease.

Chỉ Định : Investigated for use/treatment in parkinson's disease.

Tài Liệu Tham Khảo Thêm

drugbank

Bạn thấy hài lòng ?

Bạn chưa hài lòng ?

... loading